the barrier to advancing mental health treatment is measurement.
Psychiatric and neurological disorders are complicated to measure.
Existing outcome measures rely on clinician-based verbal and observational assessment of symptoms. While advancements in passive measurement have continued, Valis provides layered systems to support clinical data validation through technology solutions.
85% of CNS trials fail. 95% of Rare and Orphan trials in CNS fail.
Pharma is moving towards decentralized trials and needs validated measurement tools to enable them.
Valis is building new digital tools.
Valis is creating digital applications and tools to more accurately measure mental health disorders.
Our applications are fast to deploy, user-friendly, scientifically validated, and built by researchers for researchers.
Our products are evolving to include automated interventions to prevent relapse, suicide, and adverse events as well as digital therapies delivered through the same applications that collect data.
AI lets our applications learn from data to drive conclusions and protect patient safety
Systems integrate with decentralized clinical trial designs
Digital tools are validated and compliant with HIPAA, GDPR, CCPA (CCRA), 21 CFR Part 11, and EU-U.S. Data Privacy Framework (DPF)